Sowell Financial Services LLC Aerie Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$15.16 - $18.97 $2,016 - $2,523	-133 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $292 - $404	28 Added 26.67%	133 $2,000
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $888 - $1,193	74 Added 238.71%	105 $2,000
Q4 2019 Feb 07, 2020	BUY	$17.72 - $25.1 $549 - $778	31 New	31 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.